Company news

Anbogen Therapeutics, Inc. (TPEX:7784) news

Anbogen Therapeutics, Inc. news releases on 6ix. Latest, Aug 24, 2026: Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement…

View Anbogen Therapeutics, Inc. →

Press releases & updates

Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion

August 23, 2026